These results strongly suggest that basal levels of ACSL3 expression are sufficient to drive the lipid droplet phenotype, and that further increased expression in ccRCC is not needed to drive the clear cell phenotype. This evidence concerns the gene ACSL3 and nonpapillary renal cell carcinoma.